GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Debt-to-EBITDA

DocGo (DCGO) Debt-to-EBITDA : -4.52 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DocGo Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocGo's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $38.6 Mil. DocGo's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $18.6 Mil. DocGo's annualized EBITDA for the quarter that ended in Dec. 2024 was $-12.6 Mil. DocGo's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was -4.52.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for DocGo's Debt-to-EBITDA or its related term are showing as below:

DCGO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.5   Med: 0.6   Max: 1.48
Current: 1.25

During the past 6 years, the highest Debt-to-EBITDA Ratio of DocGo was 1.48. The lowest was -1.50. And the median was 0.60.

DCGO's Debt-to-EBITDA is ranked better than
67.32% of 456 companies
in the Healthcare Providers & Services industry
Industry Median: 2.38 vs DCGO: 1.25

DocGo Debt-to-EBITDA Historical Data

The historical data trend for DocGo's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Debt-to-EBITDA Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial -1.50 0.59 0.62 1.48 1.26

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.64 0.93 1.00 -4.52

Competitive Comparison of DocGo's Debt-to-EBITDA

For the Medical Care Facilities subindustry, DocGo's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocGo's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DocGo's Debt-to-EBITDA falls into.


;
;

DocGo Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocGo's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(38.552 + 18.635) / 45.563
=1.26

DocGo's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(38.552 + 18.635) / -12.644
=-4.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


DocGo  (NAS:DCGO) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


DocGo Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of DocGo's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


DocGo Business Description

Traded in Other Exchanges
N/A
Address
685 Third Avenue, 9th Floor, New York, NY, USA, 10017
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
Executives
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405